İ. ÇELİK Et Al. , "Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey," Virology: Research and Reviews , vol.1, no.2, pp.1-3, 2017
ÇELİK, İ. Et Al. 2017. Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey. Virology: Research and Reviews , vol.1, no.2 , 1-3.
ÇELİK, İ., BEŞTEPE DURSUN, Z., TÜRE YÜCE, Z., & İnanıcı, B., (2017). Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey. Virology: Research and Reviews , vol.1, no.2, 1-3.
ÇELİK, İLHAMİ Et Al. "Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey," Virology: Research and Reviews , vol.1, no.2, 1-3, 2017
ÇELİK, İLHAMİ Et Al. "Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey." Virology: Research and Reviews , vol.1, no.2, pp.1-3, 2017
ÇELİK, İ. Et Al. (2017) . "Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey." Virology: Research and Reviews , vol.1, no.2, pp.1-3.
@article{article, author={İLHAMİ ÇELİK Et Al. }, title={Telaprevir-based triple therapy for re-treatment Chronic HCV patients with Genotype 1, including the Null-Response: A single center experience from Turkey}, journal={Virology: Research and Reviews}, year=2017, pages={1-3} }